Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2005-06-14
2005-06-14
Horlick, Kenneth R. (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091100, C536S023100, C536S024300, C536S024330, C536S025300
Reexamination Certificate
active
06905848
ABSTRACT:
Oliognucleotide primers are provided that are specific for nucleic acid characteristic of certain beta-lactamases. The primers can be employed in methods to identify nucleic acid characteristic of family-specific beta-lactamase enzymes in samples, and particularly, in clinical isolates of Gram-negative bacteria.
REFERENCES:
patent: 4683194 (1987-07-01), Saiki et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5994066 (1999-11-01), Bergeron et al.
patent: 6001564 (1999-12-01), Bergeron et al.
patent: 6242223 (2001-06-01), Hanson et al.
patent: WO 91/08305 (1991-06-01), None
Leegaard et al., Antibiotic resistance mechanisms inSalmonellaspecies causing bacteraemia in Malawi and Kenya. APMIS, 104, 302-306, 1996.
Vahaboglu et al., Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases. J. Clin. Microbiology, 36, 827-829, Mar. 1998.
Speldooren et al., Discriminatory detection of inhibitor-resistant beta-lactamases inEscherichia coliby single-stranded conformation polymorphism-PCR. Antimicrobial Agents and Chemotherapy, 42, 879-884, Apr. 1998.
Siu et al., Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producingEnterobacteriaceae. APMIS, 106, 917-920, Sep. 1998.
Tolmasky, Sequencing and expression of aadA,bla, and tnpR from the multiresistance transposon Tn 1331. Plasmid, 24, 218-226, 1990.
Tolmssky et al., Genetic organization of antibiotic resistance genes (aac(6′)-1b, aadA, and oxa9) in the multiresistance transposon Tn 1331. Plasmid, 29, 31-40, 1993.
Rasmussen et al., Cloning and expression of a cloxacillin-hybrolyzing enzyme and a cephalosporinase fromEaeromonas sobria14M inEscherichia coli. Antimicrobial Agents and Chemotherapy, 38, 2078-2085, Sep. 1994.
Alksne et al., Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases inAeromonas jandaeiAER 14 is coordinated by a two-component regulon.
Danel et al., OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from aPseudomonas aeruginosastrain. Antimicrobial Agents and Chemotherapy, 41, 785-790, Apr. 1997.
Scoulica et al., Molecular characterization of the OXA-7 beta-lactamase gene. Antimicrobial Agents and Chemotherapy, 39, 1379-1382, Jun. 1995.
Sandvang et al., “Characterisation of integrons and antibiotic resistance genes in Danish multiresistantSalmonella entericatyphimurium DT 104,”FEMS Microbiology Letters, 157:177-181 (Dec., 1997).
Acar et al., “Nature of the Resistance Problem,”Clin. Inf. Dis., 24(Suppl 1):S1 (1997).
Arlet et al., “Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB),”FEMS Microbiol. Lett., 82:19-25 (1991).
Arlet et al., “Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases,”FEMS Microbiol. Lett., 134:203-208 (1995).
Arlet et al., “substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum β-lactamase,”FEMS Microbiol. Lett., 152:163-167 (1997).
Barnaud et al., “Cloning and sequencing of the gene encoding the AmpC β-lactamase ofMorganella morganii,” FEMS Microbiol. Lett. 148:15-20 (1997).
Bauernfeind et al., “A New Plasmidic Cefotaximase in a Clinical Isolate ofEscherichia coli,” Infection, 18(5):294-298 (1990).
Billot-Klein et al., “Nucleotide Sequence of the SHV-5 β-Lactamase Gene of aKlebsiella pneumoniaePlasmid,”Antimicrob. Agents Chemother., 34(12):2439-2441 (1990).
Birnboim et al., “A rapid alkaline extraction procedure for screening recombinant plasmid DNA,”Nucleic Acids Res., 7(6):1513-1523 (1979).
Bradford et al., “SHV-7, a Novel Cefotaxime-Hydrolyzing β-Lactamase, Identified inEscherichia coliIsolates from Hospitalized Nursing Home Patients,”Antimicrob. Agents Chemother., 39(4):899-905 (1995).
Bradford et al., “Multiply ResistantKlebsiella pneumoniaeStrains from Two Chicago Hospitals: Identification of the Extended-Spectrum TEM-12 and TEM-10 Ceftazidime-Hydrolyzing β-Lactamases in a Single Isolate,”Antimicrob. Agents Chemother., 38(4) 761-766 (1994).
Bret et al., “Chromosomally Encoded AmpC-Type β-Lactamase in a Clinical Isolate ofProteus mirabilis ,” Antimicrob. Agents Chemother., 42(5):1110-1114 (1998).
Brun-Buisson et al., “Transferable Enzymatic Resistance to Third-Generation Cephalosporins During Nosocomial Outbreak of MultiresistantKlebsiella pneumoniae,” The Lancet, 2:302-306 (1987).
Burns et al., “An Integrated Nanoliter DNA Analysis Device,”Science, 282:484-487 (1998).
Caniça et al., “Molecular Diversity and Evolution of blatemGenes Encoding β-Lactamases Resistant to Clavulanic Acid in ClinicalE. coli,” J. Mol. Evol., 44:57-65 (1997).
Carter et al., “Use of a non-radioactive hybridisation assay for direct detection of gram-negative bacteria carrying TEM β-lactamase genes in infected urine,”J. Med. Microbiol, 28:113-117 (1989).
Check, “Clinical Microbiology Eyes Nucleic Acid-Based Technologies,”ASM News, 64(2):84-89 (1998).
Crea et al., “Chemical synthesis of genes for human insulin,”Proc. Natl. Acad. Sci. USA, 75(12):5765-5769 (1978).
Crosa et al., “Plasmids,”Manual of Methods for General Bacteriology, Gerhardt et al., eds., American Society for Microbiology, Washington, DC, Ch. 15, pp. 266-282 (1981).
Curran et al., “A rapid immunoassay method for the direct detection of PCR products: application to detection of TEM β-lactamase genes,”J. Med. Microbiol., 45:76-78 (1996).
Galleni et al., “Sequence and comparative analysis of threeEnterobacter cloacaeampC β-lactamase genes and their products,”Biochem. J., 250, 753-760 (1988).
Gold et al., “Antimicrobial-Drug Resistance,”The New England Journal of Medicine, 335(19):1445-1453 (1996).
Gonzalez Leiza et al., “Gene sequence and biochemical characterization of FOX-1 fromKlebsiella pneumoniae,a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants,”Antimicrob. Agents Chemother., 38(9): 2150-7 (1994).
Hanson et al., “Molecular Charaterization of a Multiply ResistantKlebsiella pneumoniae,” Abstract C-59,37thICAAC, Toronto, Ontario, Canada, Sep. 28-Oct. 1 (1997).
Hanson et al., “A Novel TEM-Type Extended Spectrum Beta-Lactamase Expressed in Three Different Genera ofEnterobacteriaceaefrom South Africa,” Abstract C-5, pg 70,38thICAAC, San Diego, California, Sep. 24-27 (1998).
Hanson et al., “Molecular charaterization of a multiply resistantKlebsiella pneumoniaeencoding ESBLs and a plasmid-mediated AmpC,”J. Antimicrob. Chemother., 44:377-380 (1999).
Hanson et al., “Regulation of Inducible AmpC Beta-Lactamase Expression AmongEnterobacteriaceae,” Curr. Pharmac. Design, 5(11):881-894 (1999).
Hibbert-Rogers et al., “Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity,”J. Antimicrob. Chemother., 33:707-720 (1994).
Huletsky et al., “Nucleotide Sequence and Phylogeny of SHV-2 β-Lactamase,”Antimicrob. Agents Chemother., 34(9):1725-1732 (1990).
Jacoby et al., “More Extended-Spectrum β-Lactamases,”Antimicrob. Agents Chemother., 35(9):1697-1704 (1991).
Jarlier et al., “Extended Broad-Spectrum β-Lactamases Conferring Transferable Resistance to Newer β-Lactam Agents inEnterobacteriaceae: Hospital Prevalence and Susceptibility Patterns,”Rev. Infect. Dis., 10(4):867-878 (1988).
Jones, “The Emergent Needs for Basic Research, Education, and Surveillance of Antimicrobial Resistance: Problems Facing the Report from the American Society for Microbiology Task Force on Antibiotic Resistance,”Diagn. Microbiol. Infect. Disease, 25:153-161 (
Ehrhardt Anton F.
Hanson Nancy D.
Sanders Christine C.
Creighton University
Horlick Kenneth R.
Lu Frank
Mueting Raasch & Gebhardt, P.A.
LandOfFree
Primers for use in detecting beta-lactamases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Primers for use in detecting beta-lactamases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Primers for use in detecting beta-lactamases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501981